Anti-tumor effects and mechanism of the histone demethylase inhibitor GSK-J4 in non-small cell lung cancer cells
Dandan Xu, Menghan Wang, Mingyuan Wu, Yao Yu, Xingxuan Chen, Zhe Wen, Danting Shen, Tao Liu, Hong Chen · 2025
Read Anti-tumor effects and mechanism of the histone demethylase inhibitor GSK-J4 in non-small cell lung cancer cells by Dandan Xu, Menghan Wang, Mingyuan Wu, Yao Yu, Xingxuan Chen, Zhe Wen, Danting Shen, Tao Liu, Hong Chen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743077.txt.
Description
Dandan Xu and co-authors report a 2025 lab study of a drug called GSK-J4 against lung cancer cells. The drug blocks enzymes that remove chemical marks from the proteins around DNA, marks that help control which genes are on. The team tested whether the drug could slow growth and spread in two lung cancer cell lines pushed toward a more mobile state.
The drug slowed cell growth, raised cell death, and cut the cells' ability to move, invade, and shift shape. It acted through a known growth signal path inside the cells. In mice with tumors placed in the lung, the drug alone reduced tumor growth. The authors present the results as support for testing this drug approach further in this cancer type.
Catalog record
| CREATOR | Dandan Xu, Menghan Wang, Mingyuan Wu, Yao Yu, Xingxuan Chen, Zhe Wen, Danting Shen, Tao Liu, Hong Chen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |